Selected research
Market Structure
Global Bifidus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bifidus market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bifidus include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma and Shandong Zhongke Jiayi Bioengineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bifidus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bifidus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bifidus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidus market size, projected growth trends, production technologies, key applications, and end-use industries.
Bifidus Segment by Company
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Bifidus Segment by Type
Food Grade
Pharmaceutical Grade
Bifidus Segment by Application
Food & Beverages
Medicines
Health Products
Others
Bifidus Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bifidus market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bifidus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bifidus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bifidus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Pharmaceutical Grade
Applications
- Food & Beverages
- Medicines
- Health Products
- Others
Companies covered
- Chr-Hansen
- DuPont
- Wecare Probiotics
- Probi
- Mitushi Bio Pharma
- Scitop Bio-tech
- Lallemand
- Goerlich Pharma
- Shandong Zhongke Jiayi Bioengineering
- Danone
- Shanghai SPH Sinopharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bifidus Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bifidus Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bifidus Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bifidus Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bifidus Market Dynamics
- 2.1 Bifidus Industry Trends
- 2.2 Bifidus Industry Drivers
- 2.3 Bifidus Industry Opportunities and Challenges
- 2.4 Bifidus Industry Restraints
3 Bifidus Market by Manufacturers
- 3.1 Global Bifidus Revenue by Manufacturers (2021-2026)
- 3.2 Global Bifidus Sales by Manufacturers (2021-2026)
- 3.3 Global Bifidus Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bifidus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifidus Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bifidus Manufacturers, Product Type & Application
- 3.7 Global Bifidus Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bifidus Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bifidus Players Market Share by Revenue in 2025
- 3.8.3 2025 Bifidus Tier 1, Tier 2, and Tier 3
4 Bifidus Market by Type
- 4.1 Bifidus Type Introduction
- 4.1.1 Food Grade
- 4.1.2 Pharmaceutical Grade
- 4.2 Global Bifidus Sales by Type
- 4.2.1 Global Bifidus Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bifidus Sales by Type (2021-2032)
- 4.2.3 Global Bifidus Sales Market Share by Type (2021-2032)
- 4.3 Global Bifidus Revenue by Type
- 4.3.1 Global Bifidus Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bifidus Revenue by Type (2021-2032)
- 4.3.3 Global Bifidus Revenue Market Share by Type (2021-2032)
5 Bifidus Market by Application
- 5.1 Bifidus Application Introduction
- 5.1.1 Food & Beverages
- 5.1.2 Medicines
- 5.1.3 Health Products
- 5.1.4 Others
- 5.2 Global Bifidus Sales by Application
- 5.2.1 Global Bifidus Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bifidus Sales by Application (2021-2032)
- 5.2.3 Global Bifidus Sales Market Share by Application (2021-2032)
- 5.3 Global Bifidus Revenue by Application
- 5.3.1 Global Bifidus Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bifidus Revenue by Application (2021-2032)
- 5.3.3 Global Bifidus Revenue Market Share by Application (2021-2032)
6 Global Bifidus Sales by Region
- 6.1 Global Bifidus Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bifidus Sales by Region (2021-2032)
- 6.2.1 Global Bifidus Sales by Region (2021-2026)
- 6.2.2 Global Bifidus Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bifidus Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bifidus Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bifidus Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bifidus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bifidus Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bifidus Revenue by Region
- 7.1 Global Bifidus Revenue by Region
- 7.1.1 Global Bifidus Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bifidus Revenue by Region (2021-2026)
- 7.1.3 Global Bifidus Revenue by Region (2027-2032)
- 7.1.4 Global Bifidus Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bifidus Revenue (2021-2032)
- 7.2.2 North America Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bifidus Revenue (2021-2032)
- 7.3.2 Europe Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bifidus Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bifidus Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bifidus Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Chr-Hansen
- 8.1.1 Chr-Hansen Company Information
- 8.1.2 Chr-Hansen Business Overview
- 8.1.3 Chr-Hansen Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Chr-Hansen Bifidus Product Portfolio
- 8.1.5 Chr-Hansen Recent Developments
- 8.2 DuPont
- 8.2.1 DuPont Company Information
- 8.2.2 DuPont Business Overview
- 8.2.3 DuPont Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 DuPont Bifidus Product Portfolio
- 8.2.5 DuPont Recent Developments
- 8.3 Wecare Probiotics
- 8.3.1 Wecare Probiotics Company Information
- 8.3.2 Wecare Probiotics Business Overview
- 8.3.3 Wecare Probiotics Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Wecare Probiotics Bifidus Product Portfolio
- 8.3.5 Wecare Probiotics Recent Developments
- 8.4 Probi
- 8.4.1 Probi Company Information
- 8.4.2 Probi Business Overview
- 8.4.3 Probi Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Probi Bifidus Product Portfolio
- 8.4.5 Probi Recent Developments
- 8.5 Mitushi Bio Pharma
- 8.5.1 Mitushi Bio Pharma Company Information
- 8.5.2 Mitushi Bio Pharma Business Overview
- 8.5.3 Mitushi Bio Pharma Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Mitushi Bio Pharma Bifidus Product Portfolio
- 8.5.5 Mitushi Bio Pharma Recent Developments
- 8.6 Scitop Bio-tech
- 8.6.1 Scitop Bio-tech Company Information
- 8.6.2 Scitop Bio-tech Business Overview
- 8.6.3 Scitop Bio-tech Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Scitop Bio-tech Bifidus Product Portfolio
- 8.6.5 Scitop Bio-tech Recent Developments
- 8.7 Lallemand
- 8.7.1 Lallemand Company Information
- 8.7.2 Lallemand Business Overview
- 8.7.3 Lallemand Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Lallemand Bifidus Product Portfolio
- 8.7.5 Lallemand Recent Developments
- 8.8 Goerlich Pharma
- 8.8.1 Goerlich Pharma Company Information
- 8.8.2 Goerlich Pharma Business Overview
- 8.8.3 Goerlich Pharma Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Goerlich Pharma Bifidus Product Portfolio
- 8.8.5 Goerlich Pharma Recent Developments
- 8.9 Shandong Zhongke Jiayi Bioengineering
- 8.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
- 8.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
- 8.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio
- 8.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
- 8.10 Danone
- 8.10.1 Danone Company Information
- 8.10.2 Danone Business Overview
- 8.10.3 Danone Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Danone Bifidus Product Portfolio
- 8.10.5 Danone Recent Developments
- 8.11 Shanghai SPH Sinopharm
- 8.11.1 Shanghai SPH Sinopharm Company Information
- 8.11.2 Shanghai SPH Sinopharm Business Overview
- 8.11.3 Shanghai SPH Sinopharm Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Shanghai SPH Sinopharm Bifidus Product Portfolio
- 8.11.5 Shanghai SPH Sinopharm Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bifidus Value Chain Analysis
- 9.1.1 Bifidus Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bifidus Production Mode & Process
- 9.2 Bifidus Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bifidus Distributors
- 9.2.3 Bifidus Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst